Necrosis of Pedunculated Lipofibroma by Nab-Paclitaxel

We present a rare phenomenon of a soft tumor hanging on the woman’s left upper arm that underwent necrosis from the distal aspect during chemotherapy for pancreatic cancer. The benign tumor, pedunculated lipofibroma, originally had normal color for 10 years and then became necrotic when she was trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Kokubu, Hiraku, Nakanishi, Takeshi, Kato, Takeshi, Fujimoto, Noriki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10293937/
https://www.ncbi.nlm.nih.gov/pubmed/37384211
http://dx.doi.org/10.1159/000530640
_version_ 1785063091684245504
author Kokubu, Hiraku
Nakanishi, Takeshi
Kato, Takeshi
Fujimoto, Noriki
author_facet Kokubu, Hiraku
Nakanishi, Takeshi
Kato, Takeshi
Fujimoto, Noriki
author_sort Kokubu, Hiraku
collection PubMed
description We present a rare phenomenon of a soft tumor hanging on the woman’s left upper arm that underwent necrosis from the distal aspect during chemotherapy for pancreatic cancer. The benign tumor, pedunculated lipofibroma, originally had normal color for 10 years and then became necrotic when she was treated with gemcitabine and nab-paclitaxel. Necrosis stopped in conjunction with chemotherapy cessation. Dermatologists must remember that nab-paclitaxel could develop necrosis of a skin tumor.
format Online
Article
Text
id pubmed-10293937
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-102939372023-06-28 Necrosis of Pedunculated Lipofibroma by Nab-Paclitaxel Kokubu, Hiraku Nakanishi, Takeshi Kato, Takeshi Fujimoto, Noriki Case Rep Oncol Case Report We present a rare phenomenon of a soft tumor hanging on the woman’s left upper arm that underwent necrosis from the distal aspect during chemotherapy for pancreatic cancer. The benign tumor, pedunculated lipofibroma, originally had normal color for 10 years and then became necrotic when she was treated with gemcitabine and nab-paclitaxel. Necrosis stopped in conjunction with chemotherapy cessation. Dermatologists must remember that nab-paclitaxel could develop necrosis of a skin tumor. S. Karger AG 2023-05-23 /pmc/articles/PMC10293937/ /pubmed/37384211 http://dx.doi.org/10.1159/000530640 Text en © 2023 The Author(s). Published by S. Karger AG, Basel https://creativecommons.org/licenses/by-nc/4.0/This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission.
spellingShingle Case Report
Kokubu, Hiraku
Nakanishi, Takeshi
Kato, Takeshi
Fujimoto, Noriki
Necrosis of Pedunculated Lipofibroma by Nab-Paclitaxel
title Necrosis of Pedunculated Lipofibroma by Nab-Paclitaxel
title_full Necrosis of Pedunculated Lipofibroma by Nab-Paclitaxel
title_fullStr Necrosis of Pedunculated Lipofibroma by Nab-Paclitaxel
title_full_unstemmed Necrosis of Pedunculated Lipofibroma by Nab-Paclitaxel
title_short Necrosis of Pedunculated Lipofibroma by Nab-Paclitaxel
title_sort necrosis of pedunculated lipofibroma by nab-paclitaxel
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10293937/
https://www.ncbi.nlm.nih.gov/pubmed/37384211
http://dx.doi.org/10.1159/000530640
work_keys_str_mv AT kokubuhiraku necrosisofpedunculatedlipofibromabynabpaclitaxel
AT nakanishitakeshi necrosisofpedunculatedlipofibromabynabpaclitaxel
AT katotakeshi necrosisofpedunculatedlipofibromabynabpaclitaxel
AT fujimotonoriki necrosisofpedunculatedlipofibromabynabpaclitaxel

Ejemplares similares